| ES2048646B1 (en)* | 1992-04-15 | 1994-10-01 | Ercros Sa | PROCEDURE FOR THE OBTAINING OF AFRICAN EQUINE PLASTER VIRUS PROTEIN VP2 (AHSV) |
| US6090379A (en)* | 1992-04-29 | 2000-07-18 | Boyce Thompson Institute For Plant Research, Inc. | Stable pre-occluded virus particle for use in recombinant protein production and pesticides |
| CA2133649C (en)* | 1992-04-29 | 1999-04-20 | H. Alan Wood | Oral infection of insect larvae with pre-occluded baculovirus particles |
| US5593669A (en)* | 1992-04-29 | 1997-01-14 | Boyce Thompson Institute For Plant Research, Inc. | Stable pre-occluded virus particle |
| GB9924721D0 (en) | 1999-10-19 | 1999-12-22 | Craig Roger | Protein production system |
| ATE299944T1 (en)* | 1999-10-19 | 2005-08-15 | Minos Biosystems Ltd | SYSTEM FOR PRODUCING PROTEINS |
| AU2001273287A1 (en)* | 2000-07-13 | 2002-01-30 | The Curators Of The University Of Missouri | Large scale expression and purification of recombinant proteins |
| RU2239443C2 (en)* | 2002-05-27 | 2004-11-10 | Пятигорская государственная фармацевтическая академия | Drone larva homogenate and lyophilizate eliciting hypolipidemic and hepatoprotective activity |
| AU2005211385B2 (en) | 2004-02-02 | 2008-12-11 | Ambrx, Inc. | Modified human growth hormone polypeptides and their uses |
| RU2258522C1 (en)* | 2004-02-24 | 2005-08-20 | Федеральное государственное образовательное учреждение высшего профессионального образования Ставропольский государственный аграрный университет | Method for manufacturing a preparation for stimulating animal bodies out of drone bee larvae |
| BRPI0512235A (en) | 2004-06-18 | 2008-02-19 | Ambrx Inc | antigen-binding polypeptides and their uses |
| MX2007000728A (en) | 2004-07-21 | 2007-03-15 | Ambrx Inc | Biosynthetic polypeptides utilizing non-naturally encoded amino acids. |
| SG161209A1 (en) | 2004-12-22 | 2010-05-27 | Ambrx Inc | Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| EP1828224B1 (en) | 2004-12-22 | 2016-04-06 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| AU2005319518B2 (en) | 2004-12-22 | 2010-09-09 | Ambrx, Inc. | Compositions of aminoacyl-tRNA synthetase and uses thereof |
| MX2007007591A (en) | 2004-12-22 | 2007-07-25 | Ambrx Inc | Methods for expression and purification of recombinant human growth hormone. |
| KR20070090023A (en) | 2004-12-22 | 2007-09-04 | 암브룩스, 인코포레이티드 | Modified human growth hormone |
| CA2609205A1 (en) | 2005-06-03 | 2006-12-14 | Ambrx, Inc. | Improved human interferon molecules and their uses |
| EP1937824B1 (en) | 2005-08-18 | 2013-03-13 | Ambrx, Inc. | COMPOSITIONS OF tRNA AND USES THEREOF |
| US20090018029A1 (en) | 2005-11-16 | 2009-01-15 | Ambrx, Inc. | Methods and Compositions Comprising Non-Natural Amino Acids |
| CA2663083A1 (en) | 2006-09-08 | 2008-03-13 | Ambrx, Inc. | Modified human plasma polypeptide or fc scaffolds and their uses |
| MX2009002526A (en) | 2006-09-08 | 2009-04-16 | Ambrx Inc | Suppressor trna transcription in vertebrate cells. |
| US9133495B2 (en) | 2006-09-08 | 2015-09-15 | Ambrx, Inc. | Hybrid suppressor tRNA for vertebrate cells |
| CN101121938B (en)* | 2007-03-23 | 2010-10-06 | 中国农业科学院兰州兽医研究所 | Method for preparing foot-and-mouth disease antigen |
| ES2385114T3 (en) | 2007-03-30 | 2012-07-18 | Ambrx, Inc. | Modified FGF-21 polypeptides and their uses |
| CA2685596A1 (en) | 2007-05-02 | 2008-11-13 | Ambrx, Inc. | Modified interferon beta polypeptides and their uses |
| ES2632504T3 (en) | 2007-11-20 | 2017-09-13 | Ambrx, Inc. | Modified insulin polypeptides and their uses |
| US9938333B2 (en) | 2008-02-08 | 2018-04-10 | Ambrx, Inc. | Modified leptin polypeptides and their uses |
| EP2318029B1 (en) | 2008-07-23 | 2017-11-01 | Ambrx, Inc. | Modified bovine g-csf polypeptides and their uses |
| NZ592250A (en) | 2008-09-26 | 2012-11-30 | Lilly Co Eli | Modified animal erythropoietin polypeptides and their uses |
| MX357314B (en) | 2008-09-26 | 2018-07-04 | Ambrx Inc | Non-natural amino acid replication-dependent microorganisms and vaccines. |
| US20120283171A1 (en) | 2009-12-21 | 2012-11-08 | Ambrx, Inc. | Modified bovine somatotropin polypeptides and their uses |
| US20120283172A1 (en) | 2009-12-21 | 2012-11-08 | Ambrx, Inc. | Modified porcine somatotropin polypeptides and their uses |
| HUE045845T2 (en) | 2010-08-17 | 2021-12-28 | Ambrx Inc | Modified relaxin polypeptides and their use |
| US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
| TWI480288B (en) | 2010-09-23 | 2015-04-11 | Lilly Co Eli | Formulations for bovine granulocyte colony stimulating factor and variants thereof |
| PE20170950A1 (en) | 2014-10-24 | 2017-07-13 | Bristol Myers Squibb Co | MODIFIED FIBROBLAST GROWTH FACTOR 2 (FGF-21) POLYEPTIDES AND USES OF THE SAME |
| CA3052639A1 (en) | 2017-02-08 | 2018-08-16 | Bristol-Myers Squibb Company | Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof |